Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot suit helps GBS patients take steps again

NCT ID NCT07556809

Symptom relief Sponsor: Institut Guttmann Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether the Atalante X exoskeleton, a robotic leg brace, is safe and helpful for people with Guillain-Barré syndrome who cannot walk. Eleven participants used the device in 20 training sessions over six weeks. Researchers measured safety, ease of use, and any improvements in walking and muscle strength.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Atalante X exoskeleton (Wandercraft)
What this could lead to
If successful, this exoskeleton could become a safe rehabilitation tool to help people with GBS regain walking ability faster.
What could go wrong
This is a very small, early feasibility study with only 11 participants, so results may not apply to everyone. The device may not improve walking for all users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

11 people

The number who actually took part.

Started

Aug 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Guillain Barre syndrome * Receiving outpatient care and admitted at Institut Guttmann * Able to provide written informed consent * Unable to walk (FAC 0-1). Exclusion Criteria: * Ability to walk \>10 m without physical assistance or walking aids * History of lower-limb fragility fracture within the previous 2 years * Inability to tolerate 30 minutes of standing without clinical symptoms of orthostatic hypotension * Psychological or cognitive impairment preventing adherence to study procedures * Medical instability or severe comorbidities deemed by a physician to contraindicate participation * Skin lesions in areas in contact with the device * Anthropometric or anatomical constraints incompatible with the exoskeleton (e.g., height, width, weight, or relevant leg-length discrepancies) * Insufficient range of motion (ROM) for safe use of the Atalante™ exoskeleton * Known pregnancy or breastfeeding.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Guillain Barré syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Guillain-Barre syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Guillain Barré syndrome

Contacts and locations

Locations

  • Institut Guttmann

    Badalona, Barcelona, 08916, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.